Список литературы (глава 3)

1. Boehm K, Borrelli F, Ernst E, Habacher G, Hung SK, Milazzo S, Horneber M. Review: Green Tea (Camelia sinensis) for the prevention of cancer. Cochrane review prepared by Cochrane Collaboration, The Cochrane Library 2009 , Issue 3; pp 1–61.

2. Graham HN. Green tea composition, consumption, and polyphenol chemistry . Preventive Medicine 1992; 21(3): 334-50.

3. Blumenthal M. The ABC Clinical Guide to Herbs . Published by the American Botanical Council , 2003.

4. Ahmad N, Nasan M. Green tea polyphenols and cancer: biological mechanisms and practical implications . Nutrition Review 1999; 3: 78–83.

5. Demuele M, Michaud-Levesque J, Annabi B, Gingras D, Boivin D, Jodoin J, et al. Green tea catechins as novel antitumour and antiangiogenic compound. Current Medicinal Chemistry &amp; Anti-cancer Agents 2002; 2(4): 441–63.

6. Maiti FK, Chatterjee J, Dasgupta S. Efeects of green tea polyphenols on angiogenesis induced by angiogenin-like protein. Biochemical and Biophysical Research Communications 2003; 308 (1): 64–7.

7. Yang CS, Wang ZJ. Tea and cancer . Journal of the National Cancer Institute 1993; 85: 1038–49.

8. Yang CS, Lee MJ, Chen L, Yang GY. Polyphenols as inhibitors of carcinogenesis . Environmental Health Perspectives 1997; 105: (4): S971–6.

9. Komori A, Yatsunami J, Okabe S, Abe S, Hara K, Suganuma M, et al. Anticarcenogenic activity of green tea polyphenols . Japanese Journal of Clinical Oncology 1993; 23:186–90.

10. Jankun J, Selman SH, Swiercz R, Skrzypcsak-Jankun E. Why drinking green tea could prevent cancer. Nature 1997; 387: 561.

11. Su LJ, Arab L. Tea consumption and the reduced risk of colon cancer – results from a national prospective cohort study . Public Health and Nutrition 2002; 5: 419–25.

12. Yang CS, Maliaka P, Meng X. Inhibition of carcinogenesis by tea . Annual Review of Pharmacology and Toxicology 2002; 42: 25–54.

13. Zhang M, Lee AH, Binns CW, Xie X. Green tea consumption enhances survival of epithelial ovarian cancer. International Journal of Cancer 2004; 112 (3): 465–9.

14. Wang ZY, Huang MT, Lou YR, Xie JG, Reuhl KR, Newmark HL, et al. Inhibitory effects of black tea, green tea, decaffeinated black tea, and decaffeinated green tea on ultraviolet B light-induced skin carcinogenesis in 7,12-dimethylbenz(a)anthracene-initiated SKH-1 mice. Cancer Research 1994; 54(13): 3428–35.

15. Fujiki H, Suganuma M, Matsuyama S, Miyazaki K. Cancer Prevention with Green Tea Polyphenolss for the General Population . Current Cancer Therapy Reviews 2005; 1: 109–14.

16. Sun CL, Yuan JM, Lee MJ, Yang CS, Gao YT, Ross RK, et al. Urinary tea polyphenols in relation to gastric and esophageal cancers: a prospective study of men in Shanghai, China . Carcinogenesis 2002; 23 (9): 1497–1503.

17. Feifei Yu, Zhichao Jin, Hong Jiang, Chun Xiang, Jianyuan T, Tuo L, Jia H. Tea consumption and the risk of five major cancers: a dose-response meta-analysis of prospective studies .BMC Cancer 2014; 14: 197.

18. Lambert J. Does tea prevent cancer? Evidence from laboratory and human intervention studies. Am J Clin Nutr 2013, 98(6): 1667S-1675S.

19. Choan E, Segal R, Jonker D, Malone S, Reaume S, Eapen L, Gallant V.

A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach. Urol Oncol 2005, 23(2): 108–113.

20. Nguyen M, Ahmann F, Nagle R, Hsu C, Tangrea J, Parnes H, Sokoloff M, Gretzer M, Chow H. Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities. Cancer Prev Res 2012; 5(2): 290–298.

21. Tsao A, Liu D, Martin J, Tang X, Lee J, El-Naggar A, Wistuba I, Culotta K, Mao L, Gillenwater A, Sagesaka Y, Hong W, Papadimitrakopoulou V. Phaze II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral pre-malignant lesions . Cancer Prev Res 2009, 2(11): 931–941.

22. Yang G, Zheng W, Xiang YB, Gao J, Li H, Zhang X, Gao Y, Shu X. Green tea consumption and colorectal cancer risk: a report from the Shanghai Men`s Health Study . Carcinogenesis 2011, 32 (11): 1684–1688.

23. Sinha R, Cross A, Daniel C, Graubard B, Wu J, Hollenbeck A, Gunter M, Park Y, Freedman N. Caffeinated and decaffeinated coffee and tea intakes and risk of colorectal cancer in a large prospective study. Am J Clin Nutr 2012, 96(2): 374–381.

24. Maron D, Lu G, Cai N, Wu Z, Li Y, Chen H, et al. Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial . Archives of Internal Medicine 2003; 163(12): 1448–53.

25. Peters U, Poole C, Arab L. Does tea affect cardiovascular disease? A meta-analysis. American Journal of Epidemiology 2001; 154(6): 495–503.

26. Kikushi N, Ohmori K, Shimazu T, Nakaya N, Kuriyama S, Nishino Y, et al. No association between green tea and prostate cancer risk in Japanese men: the Ohsaki Cohort Study . British Journal of Cancer 2006; 95(3): 371–3.

27. Kurahashi N, Sasazuki S, Iwasaki M, Inoue M, Tsugane S. Green tea consumption and prostate cancer risk in Japanese men: a prospective study. American Journal of Epidemiology 2007; 167(1): 71–7.

28. Koizumi Y, Tsubono Y, Nakaya N, Nishino Y, Shibuya D, Matsuoka H, et al. No association between green tea and the risk of gastric cancer: pooled analysis of two prospective studies in Japan. Cancer Epidemiology Biomarkers&amp;Prevention 2003; 12(5): 472–3.

29. Sasazuki S, Inoue M, Hanaoka T, Yamamoto S, Sobue T, Tsugane S. Green tea consumption and subsequent risk of gastric cancer by subsite: the JPHC Study . Cancer Causes&amp;Control 2004; 15(5): 483–91.

30. Tsubono Y, Nishino Y, Komatsu S, Hsieh C, Kanemura S, Tsuji I, et al. Green tea and the risk of gastric cancer in Japan . New England Journal of Medicine 2001; 344(9): 632–6.

31. Huang X, Tajima K, Hamajima N, Inoue M, Takezaki T, Kuroishi T, et al. Effect of life style on ther risk of subsite-specific gastric cancer in those with and without family history . Journal of Epidemiology 1999; 9(1): 40–5.

32. Kato I, Tominaga S, Ito Y, Kobayashi S, Yoshii Y, Matsuura A, et al. A comparative case-control analysis of stomach cancer and strophic gastritis. Cancer Research 1990; 50(20): 6559–64.

33. Inoue M, Tajima K, Hirose K, Kuroishi T, Gao CM, Kitoch T. Life-style and subsite of gastric cancer – joint effect of smoking and drinking habits. International Journal of Cancer 1994; 56(4): 494–9.

34. Inoue M, Tajima K, Hirose K, Hamajima N, Takezaki T, Kuroishi T, et al. Tea and coffee consumption and the risk of difestive tract cancers: data from a comparative case-referent study in Japan. Cancer Causes&amp;Control 1998; 9(2): 209–16.

35. Yu G, Hsieh C, Wang LY, Yu S, Li X, Jin T. Green tea consumption and risk of stomach cancer: a population-based case-control study in Shanghai, China . Cancer Causes&amp;Control 1995; 6(6): 532–8.

36. Ye W, Yi Y, Luo R, Zhou T, Lin R, Chen G. Diet and gastric cancer: a case-control study in Fujian Province, China. World Journal of Gastroenterology 1998; 4(6): 516–8.

37. Kono S, Ikeda M, Tokudome S, Kuratsune M. A case-control study of gastric cancer and diet in northern Kyushu, Japan. Japanese Journal of Cancer Research 1988; 79(10): 1067–74.

38. Ji B, Chow W, Hsing A, McLaughlin J, Dai Q, Gao Y, et al. The influence of cigarette smoking, alcohol and green tea consumption on the risk of carcinoma of the cardia and distal stomach in Shaghai, China. Cancer 1996; 77(12): 2449–57.

39. Mu L, Zhou X, Ding B, Wang R, Zhang Z, Chen C, et al. A case-control study on drinking green tea and decreasing risk of cancers in the alimentary cancl among cigarette smokers and alcohol drinkers. Zhonghua Liu Xing Bing Xue Za Zhi 2003; 24(3): 192–5.

40. Wang M, Guo C, Li M. A case-control study on the dieatary risk factors of upper digestive tract cancer. Zhonghua Liu Xing Bing Xue Za Zhi 1999; 20(2): 95–7.

41. Ji B, Chow W, Yang G, MvLaughlin J, Dai Q, Gao G, et al. Green tea consumption and the risk of pancreatic and colorectal cancers . International Journal of Cancer 1997; 70(3): 255–8.

42. Goto R, Masuoka H, Yoshida K, Mori M, Miyake H. A case-control study of cancer of the pancreas . Gan No Rinsho 1990; Spec No: 344–50.

43. Luo J, Inoue M, Iwasaki M, Sasazuki S, Otani T, Ye W, et al. Green tea and coffee intake and risk of pancreatic cancer in a large-scale, population-based cohort study in Japan . European Journal of Cancer Prevention 2007; 16: 542–8.

44. Mizuno S, Watanabe S, Nakamura K, Omata M, Oguchi H, Ohashi K, et al. A multi-institute case-control study on the risk factors of developing pancreatic cancer . Japanese Journal of Clinical Oncology 1992; 22(4): 286–91.

45. Inoue M, Robien K, Wang R, Van Den Berg J, Koh W, Yu M. Green tea intake, MTHFR/TYMS genotype and breast cancer risk: the Singapore Chinese Health Study. Carcinogenesis 2008; 16(5): 185–92.

46. Suzuki Y, Tsubono Y, Nakaya N, Suzuki Y, Koizumi Y, Tsuji I. Green tea and the risk of breast cancer: pooled analysis of two prospective studies in Japan. British Journal of Cancer 2004; 90(7): 1361–3.

47. Wu A, Yu M, Tseng C, Hankin J, Pike M. Green tea and risk of breast cancer in Asian Americans . International Journal of Cancer 2003;106(4): 574–9.

48. Zhang M, Holman C, Huang J, Xie X. Green tea and the prevention of breast cancer: a case-control study in Southeast China. Carcinogenesis 2007; 28(5): 1074–8.

49. Gao Y, McLaughlin J, Blot W, Ji B, Dai Q, Fraumeni J. Reduced risk of esophageal cancer associated with green tea consumption . Journal of the National Cancer Institute 1994; 86(11): 855–8.

50. Wang J, Xu B, Rao J, Shen H, Xue H, Jiang Q. Diet habits, alcohol drinking, tobacco smoking, green tea drinking, and the risk of esophageal squamous cell carcinoma in the Chinese population. European Journal of Gastroenterology and Hepatology 2007; 19(2): 171–6.

51. Zhang M, Binns C, Lee A. Tea consumption and ovarian cancer risk: a case-control study in China. Cancer Epidemiology Biomarkers &amp; Prevention 2002; 11(8): 713–8.

52. Song Y, Kristal A, Wicklund K, Cushing-Haugen K, Rossing M.Coffee, tea, colas, and risk of epithelial ovarian cancer. Cancer Epidemiology Biomarkers&amp;Prevention 2008; 17(3): 712–6.

53. Li Q, Kakizaki M, Kuriyama S, Sone T, Yan H, Nakaya N, et al. Green tea consumption and lung cancer risk: the Ohsaki study . British Journal of Cancer 2008; 99: 1179–84.

54. Zhong L, Goldberg M, Gao Y, Hanley J, Parent M, Jun F. A population-based case-control study of lung cancer and green tea consumption among women living in Shanghai, China. Epidemiology 2001; 12(6): 695–700.

55. Bonner M, Rothman N, Mumford J, He X, Shen M, Welch R, et al. Green tea consumption, genetic susceptibility, PAH-rich smoky coal, and the risk of lung cancer. Mutation Research 2005; 582(1–2): 53–60.

56. Chyou P, Nomura A, Stemmermann G. A prospective study of diet, smoking, and lower urinary tract cancer. Annals of Epidemiology 1993; 3(3): 211–6.

57. Wakai K, Hirose K, Takezaki T, Hamajima N, Ogura J, Nakamura S, et al. Foods and beverages in relation to urothelial cancer: case-control study in Japan . International Journal of Urology 2004; 11(1): 11–9.

58. Zheng J, Yang J, Fu Y, Huang T, Huang Y, Li D. Effects of green tea, black tea, and coffee consumption on the risk of esophageal cancer: a systemic review and meta-analysis of observational studies. Nutr Cancer 2013; 65(1): 1–16.

59. Yoshiharu H, Takeshi K, Yoshihiko M, Tetsuya M, Noritaka T, et al. Green tea and stomach cancer – a short review of prospective studies . J Epidemiology 2005; 15:S109-S112.

60. Green CJ, Palina de Dauwe, Boyle T, Seyed M, Lin F, Heywoth JS. Tea, coffee, and milk consumption and colorectal cancer risk. J Epidemiology 2014;24(2): 146–153.

61. Yang C, Wang Z. Tea and cancer . J Natl Cancer Inst 1993;85(13): 1038–49.

62. Wang Z, Ohnaka K, Morita M, Toyomura K, Kono S, Ueki T, et al. Dietary polyphenols and colorectal cancer risk: the Fukuoka colorectal cancer study . World J Gastroenterology 2013; 19(17): 2683–90.

63. Hjartaker A, Aagnes B, Robsahm T, Langseth H, Bray F, Larsen I. Subsite-specific dieatary risk factors for colorectal cancer: a review of cohort studies. J Oncol 2013; pp. 703–854.

64. Jusheng Zheng, Bin Yang, Tao Huang, Yinghua Yu, Jing Yang and Duo Li. Green tea and black tea consumption and prostate cancer risk: an exploratory meta-analysis of observational studies. Nutrition and Cancer 2011, volume 63, issue 5: pp 663–672.

65. Wu Y, Liang C, Zhou F, Gao X, Chen L. A case-control tudy of environmental and genetic factors and prostate cancer in Guangdong, China . Chin J Prev Med 2009; 43: 581–585.

66. Jian L, Xie L, Lee A, Binns C. Protective effect of green tea against prostate cancer: a case-control study in southeast China . Int J Cancer 2004; 108: 130–135.

67. Maurizio B, Saverio B, Giancarlo P, Federica R, Arnaldo C. Inhibition of human prostate cancer progression by administration of green tea catechins: a two-years later follow-up update. J Urology 2008, 179: 224.

68. Tang N, Wu Y, Zhou B, Yu R. Green tea, black tea consumption and risk of lung cancer: meta-analysis. Lung Cancer 2009; 65(3): 274–83.

69. Janet S, Hilderbrand, Alpa V Patel, Marjorie L McCullough, mia M Gaudet, Amy Y.Chen, Richard B Hayes, and Susan M Gapstur. Coffee, tea, and fatal oral/pharyngeal cancer in a large prospective US cohort . Am J Epidemiol 2013; 177(1): 50–58.

70. Huang C, Lee W, Tsai S, Ou C, Lo H, et al. Tea consumption and risk of head and neck cancer. PlosONE 2014; 9(5): e96507. doi:10.1371/journal.pone.0096507

71. Malerba S, Galeone C, Pelucchi C, Turati F, Hashibe M, carlo La Vecchia, Tavani A. A meta-analysis of coffee and tea consumption and the risk of glioma in adults. Cancer Causes&amp;Control 2013; 24: 267–276.

72. Gardener H, Rundek T, Wright C, Mitchell S V Elkind, Sacco R. Coffee and tea consumption are inversely associated with mortality in a multiethnic urban population . J Nutr 2013; 143: 1299–1308.

73. Nakachi K, Suemasu K, Suga K, Takeo T, Imai K, Higashi Y. Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res 1998;89: 254–261.

74. Inoue M, Tajima K, Mizutani M, Iwata H, Iwase T, Miura S, Hirose K, Hamajima N, Tominaga S. Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan . Cancer Lett 2001; 167: 175–182.

75. Tao M, Liu D, Gao L, Jin F. Association between green tea drinking and breast cancer risk. Tumor 2002; 22: 11–15.

76. Shrubsole MJ, Lu W, Chen Z, Shu XO, Zheng Y, Dai Q, Cai Q, Gu K, Ruan ZX, Gao YT, et al. Drinking green tea modestly reduces breast cancer risk . J Nutr 2009; 139: 310–316.

77. Min-Jing Li, Yan-Cun Yin, Jiao Wang, and Yang-Fu Jiang. Green tea compounds in breast cancer prevention and treatment. World J Clin Oncol 2014; 5(3): 520–528.

78. Chung FL, Schwartz J, Herzog CR, Yang YM. Tea and cancer prevention: studies in animals and humans . J Nutr 2003; 133: 3268S–3274S.

79. Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, Paterson AD. Mammographic breast density as an intermediate phenotype for breast cancer . Lancet Oncol . 2005; 6: 798–808.

80. Khafif A, Schantz SP, al-Rawi M, Edelstein D, Sacks PG. Green tea regulates cell cycle progression in oral leukoplakia. Head Neck 1998; 20: 528–34.

81. Yuan JM.Cancer prevention by green tea: evidence from epidemiologic studies. Am J Clin Nutr 2013; 98(6): 1676S-1681S.

82. Yoon AJ, Shen J, Santella RM, Philipone EM, Wu HC, Eisig SB, Blitzer A, Close LG, Zegarelli DJ. Topical Application of Green Tea Polyphenol (-)-Epigallocatechin-3-gallate (EGCG) for Prevention of Recurrent Oral Neoplastic Lesions. J Orofac Sci. 2012; 4(10): 43–50.

83. Jing Wang, Wei Zhang, Lu Sun,Herbert Yu,Quan-Xing Ni,Harvey Risch,and Yu-Tang Gao. Green tea drinking and risk of pancreatic cancer: a large-scale, population-based case-control study in urban Shanghai. Cancer Epidemiol 2012; 36(6): e354–e358.

84. Hou IC, Amarnani S, Chong MT, Bishayee A. Green tea and the risk of gastric cancer: epidemiological evidence. World J Gastroenterol 2013; 28: 19(24): 3713–22.

85. Gao M, Ma W, Chen XB, Chang ZW, Zhang XD, Zhang MZ. Meta-analysis of green tea drinking and the prevalence of gynecological tumors in women. Asia Pac J Public Health 2013; 25(4 Suppl): 43S-8S.

86. Lee AH, Su D, Pasalich M, Binns CW. Tea consumption reduces ovarian cancer risk. Cancer Epidemiol. 2013;37(1): 54–9.

87. Andreia Henriques, Regina Arantes-Rodrigues, Ana I Faustino-Rocha, Catarina I Teixeira-Guedes, Jacinta Pinho-Oliveira, Daniela Talhada,Jose H Teixeira, Andreia Andrade, Bruno Colaço, Maria N Paiva-Cardoso,Maria J Pires, Ana MVD Ferreira, Fernando M Nunes, 4 and Paula A Oliveira. The effects of whole green tea infusion on mouse urinary bladder chemical carcinogenesis. Iran J Basic Med Sci 2014; 17(2): 145–148.

88. Woolcott CG, King WD, Marrett LD. Coffee and tea consumption and cancers of the bladder, colon and rectum . Eur J Cancer Prev . 2002; 11: 137–45.

89. Slattery ML, West DW, Robison LM. Fluid intake and bladder cancer in Utah . Int J Cancer . 1988; 42: 17–22.

90. Bruemmer B, White E, Vaughan TL, Cheney CL. Fluid intake and the incidence of bladder cancer among middle-aged men and women in a three-county area of western Washington. Nutr Cancer . 1997; 29: 163–8.

91. De Stefani E, Boffetta P, Deneo-Pellegrini H, Correa P, Ronco AL, Brennan P, Ferro G, Acosta G, Mendilaharsu M. Non-alcoholic beverages and risk of bladder cancer in Uruguay . BMC Cancer . 2007; 7:57.

92. Lu CM, Lan SJ, Lee YH, Huang JK, Huang CH, Hsieh CC. Tea consumption: fluid intake and bladder cancer risk in Southern Taiwan . Urology . 1999; 54: 823–8.

93. Jensen OM, Wahrendorf J, Knudsen JB, Sorensen BL. The Copenhagen case-control study of bladder cancer. II. Effect of coffee and other beverages. Int J Cancer . 1986; 37: 651–7.

94. La vecchia C, Negri E, Franceschi S, D Avanzo B, Boyle P. Tea consumption and cancer risk . Nutr Cancer . 1992; 17: 27–31.

95. Avanzo B, La Vecchia C, Franceschi S, Negri E, Talamini R, Buttino I. Coffee consumption and bladder cancer risk. Eur J Cancer . 1992; 28: 1480–4.

96. Ros MM, Bas Bueno de-Mesquita HB, Buchner FL, Aben KK, Kampman E, Egevad L, et al. Fluid intake and the risk of urothelial cell carcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer . 2011; 128: 2695–708.

97. Bates MN, Hopenhayn C, Rey OA, Moore LE. Bladder cancer and mate consumption in Argentina: a case-control study . Cancer Lett . 2007; 246: 268–73.

98. Jiang X, Castelao JE, Groshen S, Cortessis VK, Shibata DK, Conti DV, Gago-Dominguez M. Water intake and bladder cancer risk in Los Angeles County . Int J Cancer. 2008; 123: 1649–56.

99. Bianchi GD, Cerhan JR, Parker AS, Putnam SD, See WA, Lynch CF, Cantor KP. Tea consump tion and risk of bladder and kidney cancers in a population-based case-control study . Am J Epidemiol . 2000; 151: 377–83.

100. Wilkens LR, Kadir MM, Kolonel LN, Nomura AM, Hankin JH. Risk factors for lower urinary tract cancer: the role of total fluid consumption, nitrites and nitrosamines, and selected foods. Cancer Epidemiol Biomarkers Prev . 1996; 5: 161-6.

101. Nagano J, Kono S, Preston DL, Moriwaki H, Sharp GB, Koyama K, Mabuchi K. Bladder-cancer incidence in relation to vegetable and fruit consumption: a prospective study of atomic-bomb survivors. Int J Cancer . 2000; 86: 132–8.

102. Kurahashi N, Inoue M, Iwasaki M, Sasazuki S, Tsugane S. Coffee, green tea, and caffeine consumption and subsequent risk of bladder cancer in relation to smoking status: a prospective study in Japan. Cancer Sci . 2009; 100: 294–91.

103. Hemelt M, Hu Z,Zhong Z, Xie LP, Wong YC, Tam PC, et al. Fluid intake and the risk of bladder cancer: results from the South and East China case-control study on bladder cancer . Int J Cancer . 2010; 127: 638–45.

104. Wakai K, Hirose K, Takezaki T, Hamajima N, Ogura Y, Nakamura S, Hayashi N, Tajima K. Foods and beverages in relation to urothelial cancer: case-control study in Japan. Int J Urol. 2004; 11: 11–9.

105. Kunze E, Chang-Claude J, Frentzel-Beyme R. Life style and occupational risk factors for bladder cancer in Germany. A case-control study . Cancer . 1992; 69: 1776–90.

106. Nomura AM, Kolonel LN, Hankin JH, Yoshizawa CN. Dietary factors in cancer of the lower urinary tract . Int J Cancer . 1991; 48: 199–205.

107. Ohno Y, Aoki K, Obata K, Morrison AS. Case-control study of urinary bladder cancer in metropolitan Nagoya. Natl Cancer Inst Monogr . 1985; 69: 229–34.

108. Demirel F, Cakan M, Yalcinkaya F, Topcuoglu M, Altug U. The association between personal habits and bladder cancer in Turkey. Int Urol Nephrol . 2008; 40: 643–7.

109. Wu S, Li F, Huang X, Hua Q, Huang T, Liu Z, Liu Z, Zhang Z, Liao C, Chen Y, Shi Y, Zeng R, Feng M, Zhong X, Long Z, Tan W, Zhang X. The association of tea consumption with bladder cancer risk: a meta-analysis . Asia Pac J Clin Nutr. 2013; 22(1): 128–37.

110. Bohn SK, Blomhoff R, Paur I. Coffee and cancer risk, epidemiological evidence, and molecular mechanisms. Mol Nutr Food Res. 2014 May; 58(5): 915–30.

111. Hu M. L. Dietary polyphenols as antioxidants and anticancer agents: More questions than answers. Chang Gung Med. J . 2011; 34: 449–460.

112. Williams R. J., Spencer J. P., Rice-Evans C. Flavonoids: Antioxidants or signalling molecules? Free Radic. Biol. Med . 2004; 36: 838–849.

113. Abraham S. K., Stopper H. Anti-genotoxicity of coffee against n-methyl- n-nitro- n-nitrosoguanidine in mouse lymphoma cells. Mutat. Res. 2004; 561: 23–33.

114. Wolfrom D., Welsch C. W. Caffeine and the development of normal, benign and carcinomatous human breast tissues: A relationship? J. Med . 1990; 21: 225–250.

115. Xie F, Wang D, Huang Z, Guo Y. Coffee consumption and risk of gastric cancer: a large updated meta-analysis of prospective studies. Nutrients. 2014 Sep 18; 6(9): 3734–46.

116. Cao S1, Liu L, Yin X, Wang Y, Liu J, Lu Z. Coffee consumption and risk of prostate cancer: a meta-analysis of prospective cohort studies. Carcinogenesis. 2014 Feb; 35(2):256–61.

117. Malerba S, Turati F, Galeone C, Pelucchi C, Verga F, La Vecchia C, Tavani A. A meta-analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular diseases. Eur J Epidemiol. 2013 Jul; 28(7): 527–39.

118. Turati F1, Galeone C, Edefonti V, Ferraroni M, Lagiou P, La Vecchia C, Tavani A. A meta-analysis of coffee consumption and pancreatic cancer. Ann Oncol. 2012 Feb; 23(2): 311–8.

119. Olsen A, Knudsen KE, Thomsen BL, Loft S, Stripp C, et al. Plasma enterolactone and breast cancer incidence by estrogen receptor status. Cancer Epidemiol Biomarkers Prev 2004; 13: 2084–2089.

120. Lee WJ, Zhu BT. Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis 2008; 27: 269–277.

121. VanderPloeg LC, Welsch CW. Inhibition by caffeine of ovarian hormone-induced mammary gland tumorigenesis in female GR mice. Cancer Lett 1991; 56: 245–50.

122. Li XJ, Ren ZJ, Qin JW, Zhao JH, Tang JH, Ji MH, Wu JZ. Coffee consumption and risk of breast cancer: an up-to-date meta-analysis. PLoS One. 2013; 8(1): e52681.

123. Cano-Marquina A, Tarin JJ, Cano A.The impact of coffee on health. Maturitas. 2013 May; 75(1): 7–21.

124. Li G1, Ma D, Zhang Y, Zheng W, Wang P. Coffee consumption and risk of colorectal cancer: a meta-analysis of observational studies. Public Health Nutr. 2013 Feb; 16(2):346–57.

125. Wendy Setiawan V, Wilkens LR, Lu SC, Hernandez BY, Le Marchand L, Henderson BE.. Association of Coffee Intake with Reduced Incidence of Liver Cancer and Death from Chronic Liver Disease in the US Multiethnic Cohort. Gastroenterology. 2014 Oct 8. pii: S0016–5085(14)01200–1.

126. Wu H, Reeves KW, Qian J, Sturgeon SR. Coffee, tea, and melanoma risk among postmenopausal women. Eur J Cancer Prev 2014 Oct 16 [Epub ahead of print].

127. Malerba S, Galeone C, Pelucchi C, Turati F, Hashibe M, La Vecchia C, Tavani A. A meta-analysis of coffee and tea consumption and the risk of glioma in adults. Cancer Causes Control. 2013 Feb; 24(2): 267–76.

128. Yamada H, Kawado M, Aoyama N, Hashimoto S, Suzuki K, Wakai K, Suzuki S, Watanabe Y, Tamakoshi A; JACC Study Group.Coffee consumption and risk of colorectal cancer: the Japan Collaborative Cohort Study. J Epidemiol. 2014; 24(5): 370–8.

129. Weiderpass E, Sandin S, Lof M, Oh JK, Inoue M, Shimazu T, Tsugane S, Adami HO. Endometrial cancer in relation to coffee, tea, and caffeine consumption: a prospective cohort study among middle-aged women in sweden. Nutr Cancer. 2014 Oct; 66(7): 1132–43.

130. Harris HR, Bergkvist L, Wolk A. Coffee and black tea consumption and breast cancer mortality in a cohort of Swedish women. Br J Cancer. 2012 Aug 21; 107(5): 874–8.

131. Huang TB, Guo ZF, Zhang XL, Zhang XP, Liu H, Geng J, Yao XD, Zheng JH. Coffee consumption and urologic cancer risk: a meta-analysis of cohort studies. Int Urol Nephrol. 2014 Aug; 46(8): 1481–93.

132. Gavrilyuk O, Braaten T, Skeie G, Weiderpass E, Dumeaux V, Lund E. High coffee consumption and different brewing methods in relation to postmenopausal endometrial cancer risk in the Norwegian women and cancer study: a population-based prospective study. BMC Womens Health. 2014 Mar 25; 14:48.

133. Zamora-Ros R, Lujan-Barroso L, Bueno-de-Mesquita HB, Dik VK, Boeing H, Steffen A, Tjonneland A, Olsen A, Bech BH, Overvad K, Boutron-Ruault MC, Racine A, Fagherazzi G, Kuhn T, Katzke V, Trichopoulou A, Lagiou P, Trichopoulos D, Tumino R, Panico S, Vineis P, Grioni S, Palli D, Weiderpass E, Skeie G, Huerta JM, Sanchez MJ, Argüelles M, Amiano P, Ardanaz E, Nilsson L, Wallner B, Lindkvist B, Wallstrom P, Peeters PH, Key TJ, Khaw KT, Wareham NJ, Freisling H, Stepien M, Ferrari P, Gunter MJ, Murphy N, Riboli E, Gonzalez CA.Tea and coffee consumption and risk of esophageal cancer: the European prospective investigation into cancer and nutrition study . Int J Cancer. 2014 Sep 15; 135(6): 1470–9.

134. Hildebrand JS, Patel AV, McCullough ML, Gaudet MM, Chen AY, Hayes RB, Gapstur SM.Coffee, tea, and fatal oral/pharyngeal cancer in a large prospective US cohort. Am J Epidemiol. 2013 Jan 1; 177(1): 50–8.

135. Bhoo-Pathy N, Uiterwaal CS, Dik VK, Jeurnink SM, Bech BH, Overvad K, Halkj?r J, Tjonneland A, Boutron-Ruault MC, Fagherazzi G, Racine A, Katzke VA, Li K, Boeing H, Floegel A, Androulidaki A, Bamia C, Trichopoulou A, Masala G, Panico S, Crosignani P, Tumino R, Vineis P, Peeters PH, Gavrilyuk O, Skeie G, Weiderpass E, Duell EJ, Arguelles M, Molina-Montes E, Navarro C, Ardanaz E, Dorronsoro M, Lindkvist B, Wallstrom P, Sund M, Ye W, Khaw KT, Wareham N, Key TJ, Travis RC, Duarte-Salles T, Freisling H, Licaj I, Gallo V, Michaud DS, Riboli E, Bueno-De-Mesquita HB. Intake of coffee, decaffeinated coffee, or tea does not affect risk for pancreatic cancer: results from the European Prospective Investigation into Nutrition and Cancer Study. Clin Gastroenterol Hepatol. 2013 Nov; 11(11): 1486–92.

136. Zheng JS, Yang J, Fu YQ, Huang T, Huang YJ, Li D.Effects of green tea, black tea, and coffee consumption on the risk of esophageal cancer: a systematic review and meta-analysis of observational studies. Nutr Cancer. 2013; 65(1): 1–16.

137. Braem MG, Onland-Moret NC, Schouten LJ, Tjonneland A, Hansen L, Dahm CC, Overvad K, Lukanova A, Dossus L, Floegel A, Boeing H, Clavel-Chapelon F, Chabbert-Buffet N, Fagherazzi G, Trichopoulou A, Benetou V, Goufa I, Pala V, Galasso R, Mattiello A, Sacerdote C, Palli D, Tumino R, Gram IT, Lund E, Gavrilyuk O, Sanchez MJ, Quiros R, Gonzales CA, Dorronsoro M, Castaño JM, Gurrea AB, Idahl A, Ohlson N, Lundin E, Jirstrom K, Wirfalt E, Allen NE, Tsilidis KK, Kaw KT, Bueno-de-Mesquita HB, Dik VK, Rinaldi S, Fedirko V, Norat T, Riboli E, Kaaks R, Peeters PH. Coffee and tea consumption and the risk of ovarian cancer: a prospective cohort study and updated meta-analysis. Am J Clin Nutr. 2012 May; 95(5): 1172–81.

138. Michikawa T, Inoue M, Shimazu T, Sasazuki S, Iwasaki M, Sawada N, Yamaji T, Tsugane S. Green tea and coffee consumption and its association with thyroid cancer risk: a population-based cohort study in Japan. Cancer Causes Control. 2011 Jul; 22(7): 985–93.

139. Ganesh B1, Sushama S, Monika S, Suvarna P. A case-control study of risk factors for lung cancer in Mumbai, India. Asian Pac J Cancer Prev. 2011;12(2):357–62.

140. Wang Y, Yu X, Wu Y, Zhang D. Coffee and tea consumption and risk of lung cancer: a dose-response analysis of observational studies. Lung Cancer. 2012 Nov;78(2):169–70 .

141. Tang N, Wu Y, Ma J, Wang B, Yu R. Coffee consumption and risk of lung cancer: a meta-analysis. Lung Cancer. 2010 Jan; 67(1): 17–22.

142. Wendy S, Wilkens L, Lu S, Hernandez B, Le Marchand L, Henderson B. Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the US multiethnic cohort. Gastroenterology 2014 Oct 8. Doi: 10.1053/j.gastro.2014.10.005 (Epub ahead of print).

143. Cheng-Chin H, Wei-Ting L, Sen-Tien T, Chun-Yen O, Hung-I L, Tung-Yiu W, et al. Tea consumption and risk of head and neck cancer. Plos One 2014; 9 (5): e96507.

Задать вопрос врачу онлайн
<< | >>
Источник: Гелена Беликова. Бойкот раку. Защитите себя и своих близких! Советы врача-онколога из Великобритании: Москва; 2016. 2016

Еще по теме Список литературы (глава 3):

  5. Список литературы
  6. Список литературы
  7. Список литературы (глава 1)
  8. Список литературы (глава 2)
  9. Список литературы (глава 3)
  10. Список литературы (глава 4)
  11. Список литературы (глава 5)
  12. Список литературы (глава 6)
  13. Список литературы (глава 7)
  14. Список литературы (глава 8)
- Акушерство и гинекология - Анатомия - Биология - Болезни уха, горла и носа - Валеология - Ветеринария - Внутренние болезни - Восстановительная медицина - Гастроэнтерология и гепатология - Гематология - Геронтология, гериатрия - Гигиена и санэпидконтроль - Дерматология - Диетология - Здравоохранение - Иммунология и аллергология - Интенсивная терапия, анестезиология и реанимация - Инфекционные заболевания - Информационные технологии в медицине - История медицины - Кардиология - Клинические методы диагностики - Кожные и венерические болезни - Лучевая диагностика, лучевая терапия - Маммология - Медицина катастроф - Медицинская паразитология - Медицинская этика - Медицинские приборы - Медицинское право - Наследственные болезни - Неврология и нейрохирургия - Нефрология - Онкология - Организация системы здравоохранения - Оториноларингология - Офтальмология - Патофизиология - Педиатрия - Приборы медицинского назначения - Психиатрия - Психология - Пульмонология - Стоматология - Судебная медицина - Токсикология - Травматология - Фармакология и фармацевтика - Физиология - Фтизиатрия - Хирургия - Эмбриология и гистология - Эпидемиология -